Home/Filings/4/0001415889-24-025338
4//SEC Filing

Stanton Matthew 4

Accession 0001415889-24-025338

CIK 0001733294other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:05 PM ET

Size

8.6 KB

Accession

0001415889-24-025338

Insider Transaction Report

Form 4
Period: 2024-10-15
Stanton Matthew
CHIEF SCIENTIFIC OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-15+1,674247,811 total
  • Tax Payment

    Common Stock

    2024-10-15$2.42/sh492$1,191247,319 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-10-151,67415,059 total
    Common Stock (1,674 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
  • [F2]On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

Issuer

Generation Bio Co.

CIK 0001733294

Entity typeother

Related Parties

1
  • filerCIK 0001814198

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:05 PM ET
Size
8.6 KB